The other three are AP32788, ridaforolimus (being developed by Medinol Ltd. for use in drug-eluting stents), and rimiducid (AP1903), which is being developed by Bellicum Pharmaceuticals, Inc.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.